Themed Section: Molecular Pharmacology of GPCRs

被引：0
作者：
Summers, R. J. [1 ,2 ]
机构：
[1] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia
[2] Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2014年 / 171卷 / 05期
关键词：
molecular pharmacology < A; general fields; GPCRs; other neuropeptides; gastrointestinal pharmacology; endocrine pharmacology; anti-inflammatory drugs; anti-diabetic drugs < B; mediators; receptors; transporters; channels & ligands; drug receptor mechanisms; anticancer drugs; neuropharmacology < C; drug classes; apoptosis < D; functional systems GPCRs; RECEPTOR;
D O I：
10.1111/bph.12587
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This themed issue of the British Journal of Pharmacology stems from the 7th in the series of meetings on the Molecular Pharmacology of G Protein-Coupled Receptors (MPGPCR) held at the Monash Institute of Pharmaceutical Sciences in Melbourne Australia from the 6th-8th December 2012. Linked ArticlesThis article is part of a themed section on Molecular Pharmacology of GPCRs. To view the other articles in this section visit
引用
收藏
页码：1069 / 1072
页数：4
相关论文
共 12 条
  • [1] The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function
    Clemmensen, C.
    Smajilovic, S.
    Wellendorph, P.
    Brauner-Osborne, H.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (05) : 1129 - 1141
  • [2] WNT/Frizzled signalling: receptor-ligand selectivity with focus on FZD-G protein signalling and its physiological relevance: IUPHAR Review 3
    Dijksterhuis, J. P.
    Petersen, J.
    Schulte, G.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (05) : 1195 - 1209
  • [3] Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs
    Dong, M.
    Koole, C.
    Wootten, D.
    Sexton, P. M.
    Miller, L. J.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (05) : 1085 - 1101
  • [4] Allosteric interactions at adenosine A1 and A3 receptors: new insights into the role of small molecules and receptor dimerization
    Hill, Stephen J.
    May, Lauren T.
    Kellam, Barrie
    Woolard, Jeanette
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (05) : 1102 - 1113
  • [5] Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease
    Hollenberg, M. D.
    Mihara, K.
    Polley, D.
    Suen, J. Y.
    Han, A.
    Fairlie, D. P.
    Ramachandran, R.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (05) : 1180 - 1194
  • [6] Structure of class B GPCR corticotropin-releasing factor receptor 1
    Hollenstein, Kaspar
    Kean, James
    Bortolato, Andrea
    Cheng, Robert K. Y.
    Dore, Andrew S.
    Jazayeri, Ali
    Cooke, Robert M.
    Weir, Malcolm
    Marshall, Fiona H.
    [J]. NATURE, 2013, 499 (7459) : 438 - +
  • [7] Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders
    Leach, K.
    Sexton, P. M.
    Christopoulos, A.
    Conigrave, A. D.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (05) : 1142 - 1155
  • [8] GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation
    Lieu, T.
    Jayaweera, G.
    Bunnett, N. W.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (05) : 1156 - 1166
  • [9] The structural role of receptor tyrosine sulfation in chemokine recognition
    Ludeman, Justin P.
    Stone, Martin J.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (05) : 1167 - 1179
  • [10] Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation
    Pabreja, K.
    Mohd, M. A.
    Koole, C.
    Wootten, D.
    Furness, S. G. B.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (05) : 1114 - 1128
12